Tornier NV  

(Public, NASDAQ:TRNX)   Watch this stock  
Find more results for TRNX
24.44
-0.15 (-0.61%)
After Hours: 24.44 0.00 (0.00%)
Feb 27, 4:00PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.27 - 24.72
52 week 16.68 - 28.53
Open 24.58
Vol / Avg. 149,135.00/260,597.00
Mkt cap 1.20B
P/E     -
Div/yield     -
EPS -0.65
Shares 48.99M
Beta 1.36
Inst. own 93%
May 4, 2015
Q1 2015 Tornier NV Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 24, 2015
Q4 2014 Tornier NV Earnings Call
Feb 24, 2015
Q4 2014 Tornier NV Earnings Release
Dec 2, 2014
Tornier NV at Piper Jaffray Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -6.94% -11.71%
Operating margin -5.77% -8.10%
EBITD margin - 5.22%
Return on average assets -3.14% -5.36%
Return on average equity -4.26% -7.57%
Employees 1,076 -
CDP Score - -

Address

Prins Bernhardplein 200
SCHIEDAM, 1097 JB
Netherlands
+31-20-6754002 (Phone)
+31-10-4718888 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Tornier N.V. (Tornier) is a global medical device company focused on surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. The Company sells a broad line of joint replacement, trauma, sports medicine and biologic products to treat extremity joints. The products are focused on Upper extremity joints and trauma, Lower extremity joints and trauma, Sports medicine and biologics, and Large joints and other. Its trademarks are Aequalis, Aequalis Ascend, Aequalis Ascend Flex, Aequalis Fracture, Aequalis IM Nail, Aequalis Primary, Aequalis Reversed Fracture, Aequalis Reversed II, ArthroTunneler, BioFiber, Cannulink, Conexa, Force Fiber, Insite, Insite FT, Latitude, Latitude EV, MaxLock, MaxLock Extreme, MiniMaxLock, Phantom Fiber, Piton, PYC Humeral Head, Salto, Salto Total Ankle, Salto Talaris, Simpliciti and Tornier.

Officers and directors

David H. Mowry President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Shawn T. McCormick Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Terry M. Rich Senior Vice President - U.S. Commercial Operations
Age: 45
Bio & Compensation  - Reuters
Gordon W. Van Ummersen Senior Vice President of Global Product Delivery
Bio & Compensation  - Reuters
Gregory Morrison Global Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters
Kevin M. Klemz Vice President, Chief Legal Officer, Secretary
Age: 51
Bio & Compensation  - Reuters
Stephan Epinette Vice President - International Commercial Operations
Bio & Compensation  - Reuters
Sean D. Carney Non-Executive Independent Chairman of the Board
Age: 45
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Interim Non-Executive Independent Vice Chairman of the Board
Age: 58
Bio & Compensation  - Reuters
Alain Tornier Non-Executive Director
Age: 66
Bio & Compensation  - Reuters